Ischemic stroke is an acute vascular event that compromises neuronal viability, and identification of the patho-30 physiological mechanisms is critical for its correct management. Ischemia produces increased nitric oxide synthe-31 sis to recover blood flow but also induces a free radical burst. Nitric oxide and superoxide anion react to generate 32 peroxynitrite that nitrates tyrosines. We found that fibrinogen nitrotyrosination was detected in plasma after the 33 initiation of ischemic stroke in human patients. Electron microscopy and protein intrinsic fluorescence showed 34 that in vitro nitrotyrosination of fibrinogen affected its structure. Thromboelastography showed that initially 35 fibrinogen nitrotyrosination retarded clot formation but later made the clot more resistant to fibrinolysis. This re-36 sult was independent of any effect on thrombin production. Immunofluorescence analysis of affected human 37 brain areas also showed that both fibrinogen and nitrotyrosinated fibrinogen spread into the brain parenchyma 38 after ischemic stroke. Therefore, we assayed the toxicity of fibrinogen and nitrotyrosinated fibrinogen in a human 39 neuroblastoma cell line. For that purpose we measured the activity of caspase-3, a key enzyme in the apoptotic 40 pathway, and cell survival. We found that nitrotyrosinated fibrinogen induced higher activation of caspase 3. 41 Accordingly, cell survival assays showed a more neurotoxic effect of nitrotyrosinated fibrinogen at all concentra-42 tions tested. In summary, nitrotyrosinated fibrinogen would be of pathophysiological interest in ischemic stroke 43 due to both its impact on hemostasis -it impairs thrombolysis, the main target in stroke treatments -and its 44 neurotoxicity that would contribute to the death of the brain tissue surrounding the infarcted area. 
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Ischemic stroke is an acute vascular event that compromises neuronal viability, and identification of the patho-30 physiological mechanisms is critical for its correct management. Ischemia produces increased nitric oxide synthe-31 sis to recover blood flow but also induces a free radical burst. Nitric oxide and superoxide anion react to generate 32 peroxynitrite that nitrates tyrosines. We found that fibrinogen nitrotyrosination was detected in plasma after the 33 initiation of ischemic stroke in human patients. Electron microscopy and protein intrinsic fluorescence showed 34 that in vitro nitrotyrosination of fibrinogen affected its structure. Thromboelastography showed that initially 35 fibrinogen nitrotyrosination retarded clot formation but later made the clot more resistant to fibrinolysis. This re-36 sult was independent of any effect on thrombin production. Immunofluorescence analysis of affected human 37 brain areas also showed that both fibrinogen and nitrotyrosinated fibrinogen spread into the brain parenchyma 38 after ischemic stroke. Therefore, we assayed the toxicity of fibrinogen and nitrotyrosinated fibrinogen in a human 39 neuroblastoma cell line. For that purpose we measured the activity of caspase-3, a key enzyme in the apoptotic 40 pathway, and cell survival. We found that nitrotyrosinated fibrinogen induced higher activation of caspase 3.
41 Accordingly, cell survival assays showed a more neurotoxic effect of nitrotyrosinated fibrinogen at all concentra-42 tions tested. In summary, nitrotyrosinated fibrinogen would be of pathophysiological interest in ischemic stroke 43 due to both its impact on hemostasis -it impairs thrombolysis, the main target in stroke treatments -and its 44 neurotoxicity that would contribute to the death of the brain tissue surrounding the infarcted area.
Introduction
51
Stroke is a leading cause of death and disability worldwide [1, 2] . The 52 effectiveness of ischemic stroke treatment depends on its rapid and 53 accurate diagnosis [3] . The currently available treatment target is clot 54 lysis with recombinant tissue plasminogen activator (rtPA) but carries 55 a certain risk of bleeding and less than 5% of stroke patients receive 56 this treatment due to the very narrow therapeutic window for rtPA 57 (4.5 h after stroke onset) [4] .
58
Ischemic stroke is an acute vascular event that hinders blood supply 59 to the brain and leads to an ischemic process that affects neurons, glial 60 cells and vessels. The tissue surrounding the ischemic core lesion is Biochimica et Biophysica Acta xxx (2014) xxx-xxx Abbreviations: Ab, antibody; BSA, bovine serum albumin; CP, cortical perfusion; FBS, fetal bovine serum; GSH, reduced glutathione; MCA, middle cerebral artery; MG, methylglyoxal; MTT, 3-(4,5-dimethylthiazol-2-yl)2,5-diphenyltetrazolium bromide; nNOS, neuronal nitric oxide synthase; NO, nitric oxide; NTyr, 3-nitrotyrosine; O 2 .
259
We focused our attention on fibrinogen, which is the third most with the nitrotyrosination staining in the parenchyma from an ischemic 265 stroke patient (Fig. 1A) .
266
We then analyzed nitrotyrosination of plasma fibrinogen in both an The presence of nitrotyrosinated fibrinogen was also measured in in non-treated fibrinogen (Fig. 2B) .
304
In order to analyze the impact of fibrinogen nitrotyrosination on ( Fig. 3C) but not in the control clots (Fig. 3A ) or those treated with 312 H 2 O 2 alone (Fig. 3E) . Nitrative stress also affected the coagulation pro- (Table 1) . These results could be due to a global nitrotyrosination of 326 the proteins and factors that act in the coagulation cascade.
327
The coagulation cascade is composed of the intrinsic and the extrin- nitro-oxidative stress and changes in the coagulation cascade was cor-341 roborated when plasma samples were nitrotyrosinated in vitro (Fig. S5 ).
342
Considering that nitrotyrosination might affect various proteins be-343 sides fibrinogen (Fig. S3) , ExTEM was used to analyze the effect of 344 nitrotyrosination on the clotting process in toto ( (Table 1 ; p b 0.05).
361
Thromboelastograms also show a decrease in the width of 362 nitrotyrosinated clots (Fig. 3D) , an effect directly related to the low firm- 
Discussion
385
In an ischemic stroke the tissue responds with a cascade of events 386 that aims to protect the damaged brain, e.g. increased NO production 387 to vasodilate and maintain blood perfusion [28] . Moreover, ischemia re-388 sults in mitochondrial dysfunction, which in turn leads to a burst in free 389 radical production [8] , and the generation of peroxynitrite [29] . Subse-390 quent protein nitrotyrosination, which participates in massive tissue 391 parenchyma damage, will be largely responsible for cell death. 
peroxynitrite formation. The drop in the levels of GSH associated with 429 aging constitutes a major risk factor for stroke [35] [36] [37] , and polymor-430 phisms in some enzymes related to GSH biosynthesis have been related 431 to a higher risk of stroke [38] [39] [40] . Therefore, it is plausible to think that 432 circulating GSH avoids protein nitrotyrosination in basal conditions, and 433 that this protective mechanism might be compromised in subjects that 434 are susceptible to suffering stroke.
435
Fibrinogen is also a known pro-inflammatory agent in the brain [41] .
436
The increased permeability of the blood brain barrier during ischemic 437 stroke [42, 43] 
